Degradation of TRIM32 is induced by RTA for Kaposi's sarcoma-associated herpesvirus lytic replication

Yulin Zhang1, Zhongwei Dong1, Feng Gu1

  • 1MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infections Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganism and Infection, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, China.

PubMed

Insights

Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates TRIM32 during latency. Viral lytic replication triggers RTA to degrade TRIM32, promoting KSHV reactivation and potentially offering a therapeutic target for KSHV cancers.

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Trimer interacting protein 32 (TRIM32) is frequently dysregulated in various cancers.
  • Kaposi's sarcoma-associated herpesvirus (KSHV) is implicated in human malignancies, with its lytic replication playing a key role in tumorigenesis.
  • The specific function of TRIM32 in herpesvirus replication and oncogenesis is not well understood.

Purpose of the Study:

  • To investigate the role of TRIM32 in KSHV infection and replication.
  • To elucidate the mechanism by which KSHV influences TRIM32 expression.
  • To assess the therapeutic potential of targeting TRIM32 in KSHV-associated cancers.

Main Methods:

  • Analysis of TRIM32 expression in KSHV-infected cells (Primary Effusion Lymphoma - PEL cells) during latency and lytic replication.
  • Investigating the interaction between KSHV's Replication and Transcription Activator (RTA) and TRIM32.
  • Utilizing proteasome inhibitors to study TRIM32 degradation pathways.
  • Assessing the impact of TRIM32 inhibition on PEL cell proliferation, apoptosis, and KSHV lytic reactivation.

Main Results:

  • TRIM32 expression is elevated by KSHV during latency.
  • KSHV lytic replication reactivation leads to TRIM32 downregulation in PEL cells.
  • KSHV RTA directly interacts with TRIM32 and promotes its proteasomal degradation.
  • TRIM32 inhibition induces apoptosis, reduces proliferation, and enhances KSHV lytic replication and virion production.

Conclusions:

  • TRIM32 degradation, mediated by KSHV RTA, is essential for KSHV lytic replication.
  • Targeting TRIM32 degradation presents a potential therapeutic strategy for KSHV-associated cancers.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.2K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K